Matthew Henn

Chief Tech/Sci/R&D Officer en SERES THERAPEUTICS, INC. .

Fortuna: 49 099 $ al 31/03/2024

49 años

Consumer Services

Health Technology

Perfil

Matthew R.
Henn is currently the Chief Scientific Officer & Executive VP at Seres Therapeutics, Inc. He previously worked as a Director at Viral Genomics, Inc. and as a Director-Viral Genomics at The Broad Institute, Inc. Dr. Henn holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of New Hampshire.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
SERES THERAPEUTICS INC 0.04%	16/02/2024	63 436 ( 0.04% )	49 099 $	31/03/2024

Cargos activos de Matthew Henn

Empresas	Cargo	Inicio
SERES THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	07/02/2019

Todos los cargos activos de Matthew Henn

Antiguos cargos conocidos de Matthew Henn.

Empresas	Cargo	Fin
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/06/2012
Viral Genomics, Inc.	Director/Board Member	-

Ver el detalle de la experiencia de Matthew Henn.

Formación de Matthew Henn.

University of California, Berkeley	Doctorate Degree
University of New Hampshire	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Matthew Henn.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
SERES THERAPEUTICS, INC.	Health Technology

Empresas privadas	2
Viral Genomics, Inc.
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Health Technology